• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number PXC121200
Device Problems Premature Activation (1484); Difficult to Remove (1528); Material Separation (1562); Physical Resistance (2578); Difficult to Advance (2920)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/16/2015
Event Type  malfunction  
Event Description
On (b)(6) 2015 a patient with an abdominal aortic aneurysm was treated with gore® excluder® aaa endoprostheses.Following deployment of the trunk ipsilateral leg endoprosthesis, an attempt was made to advance the sheath to the contralateral gate.It was not possible to advance the sheath to the gate, so the contralateral leg endoprosthesis was advanced over a wire.Resistance was met at the contralateral gate and the device was observed to self-deploy.When the delivery catheter was removed from the patient, it was noticed that the distal olive and segment of the catheter where the device was attached, were left in the patient.The catheter olive with catheter segment were successfully retrieved from the patient.The patient did well following the procedure.
 
Manufacturer Narrative
Additional devices used: dsl1828/13379221, dsl1628/13403206, pxl161207/13140269, rlt311417, pxc121400/13273994 and plc271000/13388507.Results: a review of the manufacturing records for the device verified the lot met all pre-release specifications.The imaging evaluation stated the proximal end of the trunk does not appear to be apposed to the right wall of the proximal neck, although no contrast is visible outside implanted either at the level of malapposition or distal to it.The following additional observations were made: (b)(6) 2014 pre-operative: aortic diameter just distal to the lowest renal appears to be 25mm average and 27mm maximum.Aortic diameter ~8mm distal to the lowest renal appears to be 25mm.Aortic diameter 15mm distal to the lowest renal appears to be 23mm average and 24mm maximum.There appears to be an irregular flow lumen at the level of the distal abdominal aorta.Right common iliac diameters appear to range from 17mm ¿ 26mm.Left common iliac diameters appear to range from 12mm ¿ 24mm.Right external iliac diameters appear to range from 10mm ¿ 21mm.Left external iliac diameters appear to range from 10mm ¿ 17mm.(b)(6) 2015 intraoperative: 10:56-11:01 the trunk appears to have been deployed just distal to the lowest renal artery.There appears to be poor wall apposition along the right side of the proximal neck.11:39 access appears to have been gained to the contra-lateral side of the trunk.The contra-lateral limb appears to have deployed distal to the contra-lateral ring, with no overlap between devices.11:39-11:41 after deployment of the contra-lateral limb, there appears to be a kink in the sheath on the left.11:59 an additional device appears to have been deployed bridging the contra-lateral limb and the contra-lateral side of the trunk.12:35 there appears to be poor wall apposition at the proximal end of the trunk.The right side of the trunk does not appear to be touching the aortic wall.No contrast is visualized outside of the devices, although this cannot be definitively confirmed because of limited number of available images in this series.12:37 final angio- no contrast is visualized outside of the devices, although this cannot be definitively confirmed because of limited number of available images in this series.
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
The engineering analysis stated the following: the leading end of the delivery catheter was fractured and polyimide guidewire lumen broken off at the trailing olive junction.The guidewire and the introducer sheath were not returned, therefore unavailable for engineering evaluation.The root cause for the premature deployment could not be determined based on the currently available information.The root cause for the difficulty to advance the device could not be determined with the currently available information.The root cause for the broken of the catheter could not be determined with the currently available information.However, use outside of the ifu was reported and likely contributed to the event.Conclusion code: the gore® excluder® aaa endoprosthesis instructions for use (ifu) clearly states: warning: do not advance the device outside of the sheath.The sheath will protect the device from catheter breakage or premature deployment while tracking it into position.Warning: do not continue advancing any portion of the delivery system if resistance is felt during advancement of the guidewire, sheath, or catheter.Stop and assess the cause of resistance.Vessel or catheter damage may occur.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL SUNNYVALE B/P
1327 orleans drive
sunnyvale CA 94089
Manufacturer Contact
heidi inskeep
1500 n. 4th street
flagstaff, AZ 86004
9285263030
MDR Report Key4607005
MDR Text Key5627738
Report Number2953161-2015-00030
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative,company representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 08/31/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2017
Device Catalogue NumberPXC121200
Device Lot Number13379028
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/02/2015
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/16/2015
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received04/29/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/13/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age82 YR
-
-